The glucocorticoid receptor is a double-edged sword in prostate cancer
A recent study from the Institute of Biomedicine at the University of Eastern Finland shows…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
Pancreatic cancer spreads to liver or lung thanks to this protein
A protein called PCSK9 determines how pancreatic cancer cells metastasise to different parts of the…
Appendix cancer rising among younger generation
Justin Stebbing, Anglia Ruskin University Appendix cancer is a condition that, until recently, was so…
People with disability are dying from cancers we can actually prevent
Yi Yang, The University of Melbourne; George Disney, The University of Melbourne, and Kirsten Deane,…
Additional imaging techniques detect early stage cancers missed by mammograms in women with dense breasts
In women with dense breasts (breasts with relatively low levels of fatty tissue) and a…
ASCO 2025: Vepdegestrant could extend progression-free survival for some people with ESR1-mutated advanced breast cancer
Results from VERITAC-2, the first global phase 3 clinical trial of a PROTAC, a targeted…
ASCO 2025: Sacituzumab govitecan helps some patients with PD-L1-positive triple-negative breast cancer live longer without cancer progression
Results from an international phase 3 clinical trial show that treatment with sacituzumab govitecan and…
ASCO 2025: Molecular assay may help identify people with NSCLC who could benefit from adjuvant chemotherapy
Results from an international clinical trial show that a 14-gene molecular assay can help identify…
ASCO 2025: Post-hoc analysis demonstrates patient characteristics associated with long-term overall survival with irinotecan liposome injection in metastatic pancreatic adenocarcinoma
Late-breaking data from the Phase III NAPOLI 3 study were presented today at the 2025…
ASCO 2025: Pembrolizumab gives head and neck cancer patients extra years disease-free
An immunotherapy helps patients live years longer without their cancer getting worse or coming back,…